Owlstone Medical is a company focused on developing a non-invasive breathalyzer for disease detection and precision medicine. They aim to save lives and reduce healthcare costs by advancing early detection through their Breath Biopsy platform.

Owlstone Medical

X-ZELL is fusing multi-channel immunostaining with digital single-cell imaging technology to enable same-day cancer diagnoses from minimally invasive body liquids – ready for routine cytology.

X-ZELL

Owlstone Medical is on a mission is to save 100,000 lives and $1.5bn in healthcare costs. We have developed the Breath Biopsy platform, using breath analysis for precision medicine and the early detection of disease.

Our products and services are for research use only. Not for use in diagnostic procedures.

V Ventures

Horizons Ventures

Medtekwiz Advisory Ltd

Aviva Ventures

Ventura Capital

Foxconn Technology Group

🔬 Join our webinar 'Breath as a Biomarker Matrix: A Case Study in Liver Disease' on February 13th, 2024, featuring Dr. Giuseppe Ferrandino and Dr. Elizabeth Crone from Owlstone Medical.

👩‍🔬👨‍🔬 Discover how breath analysis provides unique insights for early diagnosis of liver disease, exploring volatile microbial metabolites' journey from blood to lungs.

📚 Case studies will spotlight at-home breath collection in decentralized clinical trials and advancements in diagnostic tools.

🔍 Tailored for researchers interested in breath biomarkers for liver disease and the evolving landscape of breath research.

Save the date – February 13th, 2024. Register now!

https://ow.ly/K0GB50QnHeK

Our poster in collaboration with the Mayo Clinic, ‘Volatile organic compounds in exhaled breath reflect physiological changes in ultramarathon runners,’ identifies potential biomarkers of exhaustive exercise by characterizing VOCs that differ in abundance between samples collected before and after an ultramarathon.🏃‍♂️

You can view the poster here👉: https://ow.ly/FknT50QAfe4 

📢We are also pleased to announce that this study has been recently published in the Journal of Breath Research! You can read the paper here👉: https://ow.ly/VNve50QAfe5

We love a challenge at Owlstone Medical!

Over the years we have finessed the Breath Biopsy Guide, a one-stop shop for everything breath research related, which has been downloaded thousands of times across the globe. 

With the launch of OMED Health, we now have our first ebook for those suffering with gut health issues! Everything you need to know about food intolerances, covers the symptoms to look out for, how to get an accurate diagnosis, and what are your treatment and monitoring options.

Well done to Madeleine Ball for producing such an engaging read, looking forward to our next ebook coming soon!

Exhaustive exercise triggers complex physiological reactions, especially in lung function. Dr Bruce Johnson unravels the biological associations of volatile organic compounds (VOCs) in exhaustive exercise in his BBCon23 talk ‘Breath Volatile Organic Compound Analysis Reveals Physiological Shifts in Ultramarathon Runners.’ 

You do not want to miss out on the Mayo Clinic’s first-of-a-kind investigation into breath VOC changes after an ultramarathon, a grueling 40-hour endurance challenge. 

Watch now: https://ow.ly/Skjg50Qb4oO

Metric
Company Name	Owlstone Medical	X-ZELL
Symbol
MSH ID	COM:OWLSTONEMEDICAL	COM:X-ZELL
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Healthcare & Health Services	Medical Technology
Country	GB	SG
Stage
Employee Count	190
Website	owlstonemedical.com	x-zell.com
LinkedIn	owlstonemedical
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:OWLSTONEMEDICAL

Owlstone Medical

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue